| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_SCMH1_0015600 | Intron-Intron | chr1:41681076-41681227 | chr1:41215404-41215555 | 152 nt | 0.3487 |
| hsa_chr1_0872000 | Intergenic-Intergenic | chr1:41691156-41691422 | chr1:41225484-41225750 | 267 nt | 0.3670 |
| hsa_SCMH1_0015700 | Intron-Intron | chr1:41704834-41705801 | chr1:41239162-41240129 | 968 nt | 0.4277 |
A study in humans demonstrated that the circSCMH1 is significantly decreased in the plasma of patients with acute ischemic stroke and is significant in predicting stroke outcomes [Wei et al. DOI:10.1186/s12883-021-02397-0]. A study in mice demonstrated that exosomes from adipose-derived stem cells delivering the circSCMH1 reduced nerve damage by promoting microglial M2 polarization [Li et al. DOI:10.1016/j.neuint.2023.105643].